BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000636 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 24, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
122,964
Total Value
$3,208,816.97
P&L
+inf% (+$642,759.12)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 22, 2026 | Grant/Award | 3,990 | $0.00 | $0.00 | 10,579 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 23, 2026 | Sale | 2,196 | $68.57 | $150,579.72 | 8,383 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 24, 2026 | Exercise/Conversion | 20,000 | $8.45 | $169,000.00 | 28,383 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 24, 2026 | Exercise/Conversion | 17,167 | $16.75 | $287,547.25 | 45,550 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 24, 2026 | Sale | 37,167 | $70.00 | $2,601,690.00 | 8,383 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 22, 2026 | Grant/Award | 5,277 | $0.00 | $0.00 | 5,277 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 24, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 19,000 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 24, 2026 | Exercise/Conversion | 17,167 | $0.00 | $0.00 | 17,167 | Direct | โ | View Details |